Navigation Links
Genetic Research Offers Insights Into Form of Malaria
Date:10/8/2008

P. vivax causes 300 million cases of the disease each year

WEDNESDAY, Oct. 8 (HealthDay News) -- The genetic structure of the malaria-causing Plasmodium vivax parasite has been described by an international team of researchers, who said the information could help in the fight against malaria.

The majority of research into malaria has focused on the Plasmodium falciparum parasite, which causes the most virulent form of the disease. But P. vivax and other parasites of the same genus as P. falciparum also cause malaria.

It's believed that P. vivax causes nearly 300 million cases of malaria worldwide each year. While it is rarely fatal, P. vivax can cause severe malaria and resistance to some drugs, the researchers said.

The U.S. Institute for Genomic Research-led study found that P. vivax is far more similar to P. falciparum than expected. The researchers identified only 150 genes specific to P. vivax.

The study also found that P. vivax may have unique routes of invasion for penetrating blood cells in which the parasite resides and multiples during its life cycle. These alternative routes of infection haven't been noted in previous research and the genetic information necessary for this to happen is written in the genome of P. vivax, the researchers said.

The findings are published in the Oct. 9 issue of Nature.

Even though P. vivax causes 300 million cases of malaria each year in countries such as Brazil, India and Papua New Guinea, there has been a tendency to underestimate the importance of research into this form of malaria, the study authors noted.

They said research into P. vivax should be included in the funding schedules of the nations leading the global fight against malaria.

More information

The U.S. Centers for Disease Control and Prevention has more about malaria.



-- Robert Preidt



SOURCE: Institut d'Investigacions Biomediques August Pi i Sunyer, news release, Oct. 8, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Many Parents Share Genetic Test Findings With Kids
2. Genetic predisposition increases childhood asthma risk
3. New Alzheimers findings: High stress and genetic risk factor lead to increased memory decline
4. Test Spots Genetic Damage Done by Smoking
5. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
6. Scientists highlight benefits of genetic research in sport, but warn of ethical concerns
7. Genetics Hold Promise, Challenges for Cancer Care
8. Researchers genetically engineer micro-organisms into tiny factories
9. Study Questions Genetic Screening for Treatable Diseases
10. Researchers provide genetic associations from a genome-wide scan for cardiovascular disease traits
11. Genetic variation affects smoking cessation treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and ... apnea using cutting-edge Oventus O2Vent technology. As many as 18 million Americans ... frequent cessation in breathing. Oral appliances can offer significant relief to about 75 ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), ... of an innovative new design of the shoulder pad. The shoulder pad provides ... while controlling your pain while using cold therapy. By utilizing ice and water that ...
(Date:10/12/2017)... Rockville, Maryland (PRWEB) , ... October 12, 2017 ... ... a magnetic drug delivery system that we intend to develop to enable prevention ... regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations (HLI), ... software tool, and the Cancer Patient Education Network (CPEN), an independent professional organization ... a new strategic alliance. , As CPEN’s strategic partner, HLI will help ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
(Date:9/19/2017)... --  ZirMed Inc ., a recognized leader in cloud-based revenue ... been ranked #1 by its users for the seventh consecutive ... Survey. ZirMed was recognized as the top-ranked end-to-end revenue cycle ... over 200 beds and holds one of the longest #1 ... ...
(Date:9/12/2017)... 12, 2017   EcoVadis , the leading platform for environmental, social ... annual edition of its Global CSR Risk and Performance Index. The report ... based on Scorecard Ratings that analyzed nearly 800,000 data points across the ... ... ...
Breaking Medicine Technology: